(2025). Protein Kinase C‐Delta (PKCδ) inhibition stabilizes endothelium and suppresses triple‐negative breast cancer (TNBC) intravasation in a microfluidic hypoxic tumor model. Bioengineering & Translational Medicine.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Protein Kinase C‐Delta (PKCδ) Inhibition Stabilizes Endothelium and Suppresses Triple‐negative Breast Cancer (TNBC) Intravasation in a Microfluidic Hypoxic Tumor Model."
Bioengineering & Translational Medicine 2025.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Protein Kinase C‐Delta (PKCδ) Inhibition Stabilizes Endothelium and Suppresses Triple‐negative Breast Cancer (TNBC) Intravasation in a Microfluidic Hypoxic Tumor Model."
Bioengineering & Translational Medicine, 2025.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.